|
Quotes & Info
|
| ACCL > SEC Filings for ACCL > Form 8-K on 31-Oct-2012 | All Recent SEC Filings |
31-Oct-2012
Results of Operations and Financial Condition, Financial Statements and Exhibits
On October 31, 2012, Accelrys, Inc. ("we", "us", "our" or the "Company") issued
a press release announcing its financial results for the quarter ended September
30, 2012. A copy of this press release is attached hereto as Exhibit 99.1.
The press release describes non-GAAP financial measures for revenue, operating
income, net income, net income per diluted share and free cash flow that include
deferred revenue fair value adjustments, acquisition-related cost of revenue,
royalty income fair value adjustments and exclude business consolidation,
transaction and restructuring costs, stock-based compensation expense, purchased
intangible asset amortization, amortization of note receivable discount, gain on
sale of real estate, write-off of lease related assets and income tax
adjustments. These financial measures are not calculated in accordance with
generally accepted accounting principles (GAAP) and are not based on any
comprehensive set of accounting rules or principles.
Management believes these non-GAAP financial measures provide a useful measure
of the Company's operating results, a meaningful comparison with historical
results and with the results of other companies and insight into the Company's
ongoing operating performance. Further, management and the Board of Directors of
the Company utilize these measures, in addition to GAAP measures, when
evaluating and comparing the Company's operating performance against internal
financial forecasts and budgets. These non-GAAP financial measures should not be
considered as a substitute for, or superior to, measures of financial
performance prepared in accordance with GAAP. In addition, these non-GAAP
financial measures may be different from non-GAAP financial measures used by
other companies. Investors are encouraged to review the reconciliation of the
non-GAAP financial measures presented in the press release to their most
directly comparable GAAP financial measures included in the press release.
As described above, the Company adjusts its GAAP financial statements for the
following items:
Deferred revenue fair value adjustment. The deferred revenue fair value
adjustment relates to our merger with Symyx Technologies, Inc. ("Symyx") on
July 1, 2010 and our acquisitions of Contur Industry Holding AB and Contur
Software AB (collectively, "Contur") on May 19, 2011 and VelQuest Corporation
("VelQuest") on December 30, 2011. At the time of each of these business
combination transactions, Symyx, Contur and VelQuest had recorded deferred
revenue related to revenue, which would be recognized in future periods as
revenue recognition criteria are satisfied. The purchase accounting guidance
required us to write down a significant portion of this deferred revenue to its
fair value as of the business combination transaction date. Consequently, on a
GAAP basis in post-acquisition periods, we do not recognize the full amount of
this deferred revenue. When measuring the performance of our business, however,
we add back non-GAAP revenue associated with the deferred revenue that would
have been recognized during the relevant accounting period but was excluded as a
result of these purchase accounting adjustments, as we believe this provides
information about the impact on operations of the acquired business in a manner
consistent with the revenue recognition for our pre-existing services. We
further believe that the inclusion of non-GAAP revenue enables investors to
better understand the impact of the acquisitions on the baseline revenue of the
Company and provides useful information to investors on revenue trends impacting
the business in the post-acquisition periods.
Acquisition-related cost of revenue. The acquisition-related cost of revenue
relates to our acquisition of VelQuest and resulted from professional service
arrangements under which resulting revenue was deferred at the acquisition date.
The acquisition-related cost of revenue is recorded as the associated revenue is
recognized. The purchase accounting rules required us to write down the
acquisition-related cost of revenue to its fair value as of the business
combination transaction date, which we estimated to be zero. When measuring the
performance of our business, however, we add back non-GAAP acquisition-related
costs of revenue, as we believe this enables investors to better understand the
impact of the acquisition on the Company and provides useful information to
investors.
Business consolidation, transaction and restructuring costs. Business
consolidation, transaction and restructuring costs consist of accounting, legal,
investment banking and other fees incurred in connection with anticipated and
completed business combinations, as well as costs incurred by the Company to
integrate acquired companies, including consultant and employee related costs
incurred during integration and transition periods. Also included are
acquisition-related contingent compensation costs, lease obligation exit costs,
facility closure costs and severance and other related costs incurred in
connection with the various restructuring activities commenced by the Company.
The Company excludes these costs because it believes they are not reflective of
ongoing operating results.
Stock-based compensation expense. Stock-based compensation expense consists of
expenses recorded for employee stock options, restricted stock units and
employee stock purchase rights. These expenses are excluded from the Company's
non-GAAP financial measures because they are non-cash expenses that the Company
believes are not reflective of ongoing operating results. Further, the Company
believes it is useful to investors to understand the impact of stock-based
compensation expense to its results of operations. Stock-based compensation
expense is recorded in the cost of revenue, product development, sales and
marketing, general and administrative and business consolidation, transaction
and restructuring costs lines in the Company's consolidated statements of
operations.
Purchased intangible asset amortization. Purchased intangible asset amortization
reflects the amortization expense recorded for intangible assets acquired
through a business combination. These expenses are excluded from the Company's
non-GAAP financial measures primarily because they are non-cash expenses that
the Company believes are not reflective of ongoing operating results. Purchased
intangible asset amortization is recorded in the amortization of completed
technology, purchased intangible asset amortization and royalty and other
income, net lines in the Company's consolidated statements of operations.
Royalty income fair value adjustment. Royalty income fair value adjustment
relates to our merger with Symyx. At the time of the merger, Symyx had recorded
deferred royalty income for advance payments received on royalty contracts, the
revenue resulting from which would be recognized in future periods over the
contractual period. The purchase accounting rules required us to write down this
amount to its fair value as of the completion of the merger, which we estimated
to be zero. We further believe that the inclusion of the royalty income fair
value adjustment enables investors to better understand the impact of the
acquisition on the Company and provides useful information to investors.
Amortization of note receivable discount. Amortization of note receivable
discount reflects the amortization of the discount on our promissory note
receivable from Intermolecular, Inc. ("IM") in connection with the sale of
certain intellectual property to IM in November 2011. We believe it is useful to
exclude the amortization of the discount on this promissory note receivable
because this incremental income is not part of our direct operations.
Gain on sale of real estate. Gain on sale of real estate relates to the sale of
real property, comprised of land and an office building located in Santa Clara,
California, which we sold in June 2012. This property was acquired as a result
of our merger with Symyx and was not utilized in our ongoing operations.
Write-off of lease related assets. Write-off of lease related assets relates to
the write off in June 2012 of certain assets in connection with exiting the
lease of a restructured facility.
Income tax. Income tax adjustments relate to adjusting our non-GAAP operating
results to reflect an effective tax rate that would be applied if the Company
was in a taxable income position and was not able to utilize its net operating
loss carryforwards. The income tax adjustment also excludes any impact of a
release of our valuation allowance against deferred tax assets.
In accordance with General Instruction B.2. of Form 8-K, the information in this
Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), or otherwise subject to the liability of that section, nor
shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933, as amended, or the Exchange Act, except as expressly set forth by
specific reference in such a filing.
(d) Exhibits
Exhibit No. Description
99.1 Press release dated October 31, 2012
|
|